Throughout 2022, MMV continued working with our partners to bring forward antimalarials to protect and cure the world’s most underserved populations, enhance control efforts and progress toward the eventual eradication and elimination of the disease globally. Our latest annual report offers an in-depth overview of MMV’s activities, achievements and financial statements for 2022. Read more. 

Before the COVID-19 pandemic, the term “global health” was often used with reference to low-and-middle-income countries. If the past two years have taught us anything, it is that we are all “global health”—North or South, microbes and particles connect us all, yet resources are unevenly distributed. Investments in combatting diseases that often occur amongst the poorest populations allow countries to build more resilient health systems. These systems can be deployed in response to the next global health emergency. Read more.